T. Rowe Price Associates
CLMT icon

T. Rowe Price Associates’s Calumet Specialty Products CLMT Stock Holding History

T. Rowe Price Associates’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.07M Buy
57,573
+7,680
+15% +$258K ﹤0.01% 1990
2026
Q1 		$1.79M Buy
49,893
+8,605
+21% +$223K ﹤0.01% 1869
2025
Q4 		$821K Buy
41,288
+3,688
+10% +$71K ﹤0.01% 2164
2025
Q3 		$687K Buy
37,600
+3,149
+9% +$51.8K ﹤0.01% 2237
2025
Q2 		$543K Buy
+34,451
New +$438K ﹤0.01% 2263

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates's CLMT Position: Q2 2026 in Review

T. Rowe Price Associates increased its Calumet Specialty Products (CLMT) stake by 15% in Q2 2026, buying an estimated $258K and bringing the position to 57,573 shares worth $2.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1990.

T. Rowe Price Associates first reported a position in CLMT in Q2 2025 and has held it in 5 quarters since. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • T. Rowe Price Associates held 57,573 shares of Calumet Specialty Products worth $2.07M as of Q2 2026.
  • T. Rowe Price Associates bought 7,680 Calumet Specialty Products shares in Q2 2026, an estimated $258K.
  • Calumet Specialty Products made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1990 holding.
  • T. Rowe Price Associates first reported a position in Calumet Specialty Products in Q2 2025 and has held it in 5 quarters since.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.